IDH3A and glioblastoma: Historically, GBM has been classified as isocitrate dehydrogenase (IDH) wild type and IDH-mutant (secondary GBM); nevertheless, according to 2021 WHO Classification of Tumors of the Central Nervous System [1], only grade 4 IDH wild type gliomas are now defined as GBMs.